Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Eloxx Pharmaceuticals Inc (ELOX)
OTHER OTC:ELOX
Holding ELOX?
Track your performance easily
ELOX Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$0.20 - $1.74
Previous Close$0.69
Volume188.00
Average Volume (3M)N/A
Market Cap
$314.00
Enterprise Value$983.31K
Total Cash (Recent Filing)$4.78M
Total Debt (Recent Filing)$5.76M
Price to Earnings (P/E)―
Beta667.34
Next Earnings
Nov 07, 2024EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-9.06
Shares Outstanding3,143,390
10 Day Avg. Volume1,498
30 Day Avg. VolumeN/A
Standard Deviation25.70
R-Squared0.00260
Alpha3.57
Financial Highlights & Ratios
Price to Book (P/B)0.00
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)0.00
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit10.00T>
Enterprise Value/Ebitda-0.05
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Eloxx Pharmaceuticals News
PremiumCompany Announcements
Eloxx Pharmaceuticals Reprices CEO Stock Options
PremiumCompany Announcements
Eloxx Pharmaceuticals CEO Stock Option Repricing Initiative
Ownership Overview
6.58% Insiders
<0.01% Other Institutional Investors
93.42% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products
ELOX FAQ
What was Eloxx Pharmaceuticals Inc’s price range in the past 12 months?
Eloxx Pharmaceuticals Inc lowest stock price was $0.20 and its highest was $1.74 in the past 12 months.
What is Eloxx Pharmaceuticals Inc’s market cap?
Currently, no data Available
When is Eloxx Pharmaceuticals Inc’s upcoming earnings report date?
Eloxx Pharmaceuticals Inc’s upcoming earnings report date is Nov 07, 2024 which is 42 days ago.
How were Eloxx Pharmaceuticals Inc’s earnings last quarter?
Currently, no data Available
Is Eloxx Pharmaceuticals Inc overvalued?
According to Wall Street analysts Eloxx Pharmaceuticals Inc’s price is currently Overvalued.
Does Eloxx Pharmaceuticals Inc pay dividends?
Eloxx Pharmaceuticals Inc does not currently pay dividends.
What is Eloxx Pharmaceuticals Inc’s EPS estimate?
Eloxx Pharmaceuticals Inc’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Eloxx Pharmaceuticals Inc have?
Eloxx Pharmaceuticals Inc has 3,143,390 shares outstanding.
What happened to Eloxx Pharmaceuticals Inc’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Eloxx Pharmaceuticals Inc?
Currently, no hedge funds are holding shares in ELOX
---
Company Description
Eloxx Pharmaceuticals Inc
Eloxx Pharmaceuticals, Inc. engages in the development of novel ribonucleic acid modulating drug candidates. The firm focuses on the the formulation of medicines to treat rare and ultra-rare premature stop codon diseases. It operates through the United States and Israel geographical segments. Its product includes ELX-02, a small molecule drug designed to restore production of full-length functional proteins which treats cystic fibrosis and cystinosis. The company was founded on December 19, 2017 and is headquartered in Waltham, MA.
---
ELOX Stock 12 Month Forecast
Average Price Target
―---